2m 2m 2m 2m 2m 2m 2m
Immucell (ICCC)
NASDAQ
$10.24-$0.010 (-0.10%)
Price as of Oct 23, 2026 4:10 PM EDT- $93.1MMarket Cap
- 68.59%1-Year Change
- BiotechnologyIndustry
Immucell (ICCC)
$10.24-$0.010 (-0.10%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 27.6M +4.34% | 26.5M +51.64% | 17.5M -5.90% | 18.6M -3.51% | |
Cost of Revenue | 16.2M -12.68% | 18.6M +36.39% | 13.6M +24.57% | 10.9M +3.14% | |
Gross Profit | 11.4M +44.13% | 7.9M +105.23% | 3.9M -49.41% | 7.6M -11.64% | |
Sales and Marketing Expense | 3.6M +2.52% | 3.5M +12.24% | 3.1M -3.19% | 3.2M +27.40% | |
Research and Development Expense | -3.0M -21.97% | -3.9M -11.29% | -4.4M -2.20% | -4.5M +7.81% | |
Depreciation and Amortization Expense | 19,104 0.00% | 19,104 0.00% | 19,104 -99.23% | 2.5M +1.08% | |
Total Operating Expenses | 9.8M +2.24% | 9.6M -0.38% | 9.6M -3.32% | 9.9M +18.45% | |
Operating Profit | 1.6M +200.56% | -1.6M -71.47% | -5.7M +150.03% | -2.3M -993.19% | |
Interest Income | 158,709 +104.25% | 77,702 -19.54% | 96,570 -36.92% | 153,100 +713.93% | |
Interest Expense | N/A N/A | -568,725 +19.58% | -475,598 +36.46% | -348,536 +10.87% | |
Interest Income and Expense and Net | 158,709 +132.32% | -491,023 +29.55% | -379,028 +93.94% | -195,436 -33.87% | |
Total Nonoperating Income and Expense | -2.7M +428.77% | -506,414 +2,213.13% | -21,893 -88.30% | -187,190 -42.67% | |
Income before Taxes | -1.0M -52.09% | -2.1M -62.80% | -5.8M +132.09% | -2.5M +3,496.47% | |
Income Taxes | 11,570 +15.06% | 10,056 +117.33% | 4,627 -39.69% | 7,672 -16.29% | |
Extraordinary Items | 2.7M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -1.0M -51.78% | -2.2M -62.65% | -5.8M +131.56% | -2.5M +3,085.26% | |
Net Income from Continuing Operations Applicable to Common | -1.0M -52.09% | -2.1M -62.80% | -5.8M +132.09% | -2.5M +3,496.47% | |
Basic EPS and Net Income | -0.12 -53.85% | -0.26 -65.33% | -0.75 +134.38% | -0.32 +3,100.00% | |
Diluted EPS and Net Income | -0.12 -53.85% | -0.26 -65.33% | -0.75 +134.38% | -0.32 +3,100.00% | |
Basic Weighted Average Shares | 9.0M +10.52% | 8.2M +5.42% | 7.7M +0.03% | 7.7M +2.01% | |
Diluted Weighted Average Shares | 9.0M +10.52% | 8.2M +5.42% | 7.7M +0.03% | 7.7M +2.01% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.8M +1.29% | 3.8M +283.99% | 978,741 -83.10% | 5.8M -43.14% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 3.8M +1.29% | 3.8M +283.99% | 978,741 -83.10% | 5.8M -43.14% | |
Total Current Assets | 16.9M +12.64% | 15.0M +25,990.97% | 57,655 -99.59% | 14.0M -13.96% | |
Accumulated Depreciation | 18.8M -10.47% | 21.0M +13.84% | 18.5M +16.43% | 15.9M +13.45% | |
Property and Plant and Equipment and Net | 21.1M -16.86% | 25.3M -8.07% | 27.6M -3.04% | 28.4M +5.76% | |
Total Long-Term Assets | 37,686 +12.94% | 33,368 -99.71% | 11.5M +14,868.22% | 76,628 +193.43% | |
Total Assets | 42.5M -5.69% | 45.1M +2.95% | 43.8M -2.35% | 44.9M +0.89% | |
Income Taxes Payable | 6,694 +15.12% | 5,815 +90.59% | 3,051 -37.61% | 4,890 +128.40% | |
Total Short-Term Debt | 1.6M +7.52% | 1.5M +4.82% | 1.4M +37.46% | 1.0M +27.98% | |
Total Current Liabilities | 4.0M -9.84% | 4.4M +5.12% | 4.2M +36.63% | 3.1M +21.21% | |
Total Long-Term Debt | 7.5M -17.17% | 9.0M -14.23% | 10.5M +14.68% | 9.2M +10.38% | |
Total Long-Term Liabilities | 11.5M -12.69% | 13.2M -9.90% | 14.6M +28.13% | 11.4M +21.96% | |
Total Liabilities | 15.5M -11.97% | 17.6M -6.55% | 18.8M +29.93% | 14.5M +21.80% | |
Retained Earnings | -15.2M +7.34% | -14.2M +17.96% | -12.0M +92.65% | -6.2M +66.70% | |
Total Stockholders Equity | 27.1M -1.68% | 27.5M +10.10% | 25.0M -17.73% | 30.4M -6.74% | |
Total Shares Outstanding | 9.0M +0.74% | 9.0M +15.85% | 7.8M +0.05% | 7.7M +0.06% | |
Cash Flow | |||||
Cash from Operating Activities | 2.5M +591.61% | 357,903 +107.66% | -4.7M +202.76% | -1.5M -261.80% | |
Capital Expenditures | 1.3M +168.49% | 465,725 -75.39% | 1.9M -52.39% | 4.0M +52.39% | |
Cash from Investing Activities | -1.2M +163.28% | -461,225 -75.60% | -1.9M -52.32% | -4.0M +148.18% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -1.2M -142.06% | 2.9M +64.60% | 1.8M +57.19% | 1.1M -71.27% | |
Financials Ratio | |||||
Gross Margin | 41.40% +38.13% | 29.97% +35.35% | 22.15% -46.24% | 41.19% -8.42% | |
Operating Margin | 5.97% +196.37% | -6.19% -81.18% | -32.90% +165.72% | -12.38% -1,025.63% | |
Return on Assets | -2.37% -51.07% | -4.85% -62.75% | -13.03% +133.27% | -5.58% +2,924.70% | |
Return on Equity | -3.81% -53.60% | -8.21% -60.62% | -20.86% +163.27% | -7.92% +2,977.78% | |
Revenue Growth | 4.34% -91.59% | 51.64% +974.55% | -5.90% +68.32% | -3.51% -113.80% | |
Current Ratio | 4.26 +24.93% | 3.41 +24,785.40% | 0.01 -99.70% | 4.56 -29.01% | |
Cash Ratio | 0.96 +12.34% | 0.85 +265.27% | 0.23 -87.63% | 1.89 -53.09% | |
Debt-to-Equity Ratio | 0.34 -12.19% | 0.38 -20.03% | 0.48 +42.19% | 0.34 +20.07% | |
Debt-to-Assets Ratio | 0.21 -8.47% | 0.23 -14.46% | 0.27 +19.77% | 0.23 +11.00% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow